Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents.

In previous studies, we identified promising anti-Trypanosoma cruzi cruzain inhibitors based on thiazolylhydrazones. To optimize this series, a number of medicinal chemistry directions were explored and new thiazolylhydrazones and thiosemicarbazones were thus synthesized. Potent cruzain inhibitors were identified, such as thiazolylhydrazones 3b and 3j, which exhibited IC(50) of 200-400nM. Furthermore, molecular docking studies showed concordance with experimentally derived structure-activity relationships (SAR) data. In the course of this work, lead compounds exhibiting in vitro activity against both the epimastigote and trypomastigote forms of T. cruzi were identified and in vivo general toxicity analysis was subsequently performed. Novel SAR were documented, including the importance of the thiocarbonyl carbon attached to the thiazolyl ring and the direct comparison between thiosemicarbazones and thiazolylhydrazones.

[1]  K. Douglas,et al.  Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease. , 2008, Drug discovery today.

[2]  Christopher P Austin,et al.  Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB. , 2010, Journal of medicinal chemistry.

[3]  J. McKerrow,et al.  A Cysteine Protease Inhibitor Cures Chagas' Disease in an Immunodeficient-Mouse Model of Infection , 2007, Antimicrobial Agents and Chemotherapy.

[4]  J. McKerrow,et al.  Identification of a new class of nonpeptidic inhibitors of cruzain. , 2008, Journal of the American Chemical Society.

[5]  R. D. dos Santos,et al.  Approaches for the development of new anti-Trypanosoma cruzi agents. , 2009, Current drug targets.

[6]  D. Moreira,et al.  Synthesis of aryl-hydrazones via ultrasound irradiation in aqueous medium , 2008 .

[7]  J. Dearden,et al.  2-Heteroarylimino-5-benzylidene-4-thiazolidinones analogues of 2-thiazolylimino-5-benzylidene-4-thiazolidinones with antimicrobial activity: synthesis and structure-activity relationship. , 2008, Bioorganic & medicinal chemistry.

[8]  U. Orlando,et al.  Sulfates are main targets of immune responses to cruzipain and are involved in heart damage in BALB/c immunized mice. , 2008, International immunology.

[9]  Kenny K H Ang,et al.  Divergent modes of enzyme inhibition in a homologous structure-activity series. , 2009, Journal of medicinal chemistry.

[10]  N. Zanatta,et al.  Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines. , 2008, Bioorganic & medicinal chemistry.

[11]  J. Scharfstein,et al.  Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells , 2005, Journal of Cell Science.

[12]  Ming Zhou,et al.  Design, synthesis, and biochemical evaluation of novel cruzain inhibitors with potential application in the treatment of Chagas' disease. , 2006, Bioorganic & medicinal chemistry letters.

[13]  B. Shoichet,et al.  Identification and prediction of promiscuous aggregating inhibitors among known drugs. , 2003, Journal of medicinal chemistry.

[14]  R. S. Ferreira,et al.  Novel non-peptidic vinylsulfones targeting the S2 and S3 subsites of parasite cysteine proteases. , 2009, Bioorganic & medicinal chemistry letters.

[15]  O. Mert,et al.  Use of Lawesson's reagent in organic syntheses. , 2007, Chemical reviews.

[16]  J. Scharfstein,et al.  Host Cell Invasion by TRYPANOSOMA cRUZI Is Potentiated by Activation of Bradykinin B2 Receptors , 2000, The Journal of experimental medicine.

[17]  Marcelo Zaldini Hernandes,et al.  Halogen atoms in the modern medicinal chemistry: hints for the drug design. , 2010, Current drug targets.

[18]  M. Soares,et al.  Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents. , 2009, Bioorganic & medicinal chemistry.

[19]  J. Dilworth,et al.  Reactivity of thiosemicarbazides with redox active metal ions: controlled formation of coordination complexes versus heterocyclic compounds. , 2009, Chemistry.

[20]  P. Gayral,et al.  Synthesis of some 4-oxo-delta 2-thiazolin-2-ylhydrazones as potential antiprotozoal agents. , 1993, Farmaco.

[21]  J. McKerrow,et al.  Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection , 1998, Journal of Experimental Medicine.

[22]  William N. Hunter,et al.  Structure-based Ligand Design and the Promise Held for Antiprotozoan Drug Discovery* , 2009, Journal of Biological Chemistry.

[23]  I. Carvalho,et al.  'Click chemistry' synthesis of a library of 1,2,3-triazole-substituted galactose derivatives and their evaluation against Trypanosoma cruzi and its cell surface trans-sialidase. , 2010, Bioorganic & medicinal chemistry.

[24]  A. Fairlamb,et al.  Bis(glutathionyl)spermine and Other Novel Trypanothione Analogues in Trypanosoma cruzi* , 2003, Journal of Biological Chemistry.

[25]  Kelly Chibale,et al.  Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi. , 2004, Journal of medicinal chemistry.

[26]  Alfredo Mayall Simas,et al.  RM1: A reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I , 2006, J. Comput. Chem..

[27]  V. Duschak,et al.  Cruzipain, the major cysteine protease of Trypanosoma cruzi: a sulfated glycoprotein antigen as relevant candidate for vaccine development and drug target. A review. , 2009, Current medicinal chemistry.

[28]  Henrique S. Oliveira,et al.  Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships. , 2009, Bioorganic & medicinal chemistry.

[29]  F. Cohen,et al.  Synthesis and structure-activity relationship study of potent trypanocidal thio semicarbazone inhibitors of the trypanosomal cysteine protease cruzain. , 2002, Journal of medicinal chemistry.

[30]  M. G. Albuquerque,et al.  Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling and SAR/QSAR studies of a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)-acrylic acid benzylidene-carbohydrazide series. , 2009, Bioorganic & medicinal chemistry.

[31]  A. Geronikaki,et al.  Synthesis and antimicrobial activity of novel 2-thiazolylimino-5-arylidene-4-thiazolidinones. , 2006, Bioorganic & medicinal chemistry.

[32]  M. Soares,et al.  Synthesis, docking, and in vitro activity of thiosemicarbazones, aminoacyl-thiosemicarbazides and acyl-thiazolidones against Trypanosoma cruzi. , 2006, Bioorganic & medicinal chemistry.

[33]  J. Cazzulo,et al.  New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuroxan heterocycle. , 2008, Bioorganic & Medicinal Chemistry.

[34]  J. Scharfstein,et al.  A New Cruzipain-Mediated Pathway of Human Cell Invasion by Trypanosoma cruzi Requires Trypomastigote Membranes , 2004, Infection and Immunity.

[35]  David S Hartsough,et al.  Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease. , 2005, Bioorganic & medicinal chemistry.

[36]  J. Gut,et al.  Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain. , 2005, Bioorganic & medicinal chemistry letters.

[37]  Christopher P Austin,et al.  Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease. , 2010, Journal of medicinal chemistry.

[38]  N. Romeiro,et al.  Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates. , 2009, Bioorganic & medicinal chemistry.

[39]  A. Majid,et al.  The therapeutic potential of statins in neurological disorders. , 2007, Current medicinal chemistry.

[40]  C. Caffrey,et al.  Kinetoplastid papain-like cysteine peptidases. , 2009, Molecular and biochemical parasitology.

[41]  Clayton Springer,et al.  CoMFA and HQSAR of acylhydrazide cruzain inhibitors. , 2002, Bioorganic & medicinal chemistry letters.

[42]  E. Ferreira,et al.  Cruzain inhibition by hydroxymethylnitrofurazone and nitrofurazone: investigation of a new target in Trypanosoma cruzi , 2009, Journal of enzyme inhibition and medicinal chemistry.

[43]  K. Ang,et al.  Nonpeptidic tetrafluorophenoxymethyl ketone cruzain inhibitors as promising new leads for Chagas disease chemotherapy. , 2010, Journal of medicinal chemistry.

[44]  L. M. Lima,et al.  Bioisosterism: a useful strategy for molecular modification and drug design. , 2005, Current medicinal chemistry.